HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy.

AbstractBACKGROUND:
Transgenic and gene-targeted models have focused on the mouse. Fundamental differences between the mouse and human exist in Ca2+ handling during contraction/relaxation and in alterations in Ca2+ flux during heart failure, with the rabbit more accurately reflecting the human system.
METHODS AND RESULTS:
Cardiac troponin I (cTnI) mutations can cause familial hypertrophic cardiomyopathy. An inhibitory domain mutation, arginine146-->glycine (cTnI(146Gly)), was modeled with the use of transgenic expression in the rabbit ventricle. cTnI(146Gly) levels >40% of total cTnI were perinatally lethal, whereas replacement levels of 15% to 25% were well tolerated. cTnI(146Gly) expression led to a leftward shift in the force-pCa2+ curves with cardiomyocyte disarray, fibrosis, and altered connexin43 organization. In isolated cTnI(146Gly) myocytes, twitch relaxation amplitudes were smaller than in normal cells, but [Ca]i transients and sarcoplasmic reticulum Ca2+ load were not different. Detrended fluctuation analysis of the QT(max) intervals was used to evaluate the cardiac repolarization phase and showed a significantly higher scaling exponent in the transgenic animals.
CONCLUSIONS:
Expression of modest amounts of cTnI(146Gly) led to subtle defects without severely affecting cardiac function. Aberrant connexin organization, subtle morphological deficits, and an altered fractal pattern of the repolarization phase of transgenic rabbits, in the absence of entropy or other ECG abnormalities, may indicate an early developing pathology before the onset of more obvious repolarization abnormalities or major alterations in cardiac mechanics.
AuthorsAtsushi Sanbe, Jeanne James, Volkan Tuzcu, Selman Nas, Lisa Martin, James Gulick, Hanna Osinska, Sadayappan Sakthivel, Raisa Klevitsky, Kenneth S Ginsburg, Donald M Bers, Bruce Zinman, Edward G Lakatta, Jeffrey Robbins
JournalCirculation (Circulation) Vol. 111 Issue 18 Pg. 2330-8 (May 10 2005) ISSN: 1524-4539 [Electronic] United States
PMID15867176 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Connexin 43
  • Troponin I
  • Calcium
Topics
  • Animals
  • Animals, Genetically Modified
  • Calcium (metabolism)
  • Cardiomegaly
  • Cardiomyopathy, Hypertrophic, Familial (genetics, pathology, physiopathology)
  • Connexin 43 (metabolism)
  • Disease Models, Animal
  • Electrocardiography
  • Fibrosis
  • Heart Function Tests
  • Heart Ventricles (metabolism)
  • Humans
  • Mutation, Missense
  • Myocytes, Cardiac (pathology)
  • Phenotype
  • Rabbits
  • Transgenes
  • Troponin I (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: